Advances in Chemoradiotherapy for Gastrointestinal Cancers: From Bench to Bedside
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 March 2024) | Viewed by 2084
Special Issue Editors
Interests: pancreatic cancer; eus; early diagnosis; chemoradiation therapy; interventional eus; gene therapy; personalized medicine; artificial intelligence
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive overview of the current advancements in chemoradiotherapy strategies for gastrointestinal (GI) cancers. It will cover preclinical and clinical research, focusing on the multidisciplinary approach to improve treatment outcomes and patient care. The Special Issue will explore novel combination therapies, including targeted agents, immunotherapy and radiation sensitizers, to enhance the efficacy of chemoradiotherapy. It will address the challenges associated with GI cancers, such as esophageal, gastric, pancreatic, liver, colorectal and biliary cancers, and discuss personalized treatment approaches. Additionally, the Special Issue will emphasize the development and application of innovative imaging techniques, radiation delivery methods and biomarkers for treatment response prediction and therapy monitoring. It will delve into supportive care strategies and the management of treatment-related toxicities to optimize patient quality of life during chemoradiotherapy. Overall, this Special Issue will serve as a platform for disseminating cutting-edge research and fostering collaborations to advance the field of chemoradiotherapy for GI cancers, ultimately leading to improved patient outcomes and survival rates.
Dr. Reiko Ashida
Dr. Ryoji Takada
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chemoradiotherapy
- pancreatic cancer
- biomarkers
- multidisciplinary approach
- gastrointestinal cancers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
